Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cytotherapy

Showing results (761-770 of 2,791) with videos related to

Pageof 280
Sort By:
Cytotherapy|January 30, 2017
CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: A pilot studySarita Rani Jaiswal, Shamsur Zaman, Murugaiyan Nedunchezhian, et al.
Cytotherapy|July 20, 2019
T-cell therapies for T-cell lymphomaKeri Toner, Catherine M Bollard, Hema Dave
Cytotherapy|September 22, 2019
Umbilical cord-derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical dataMartina Colicchia, Daniel A Jones, Anne-Marie Beirne, et al.
Cytotherapy|September 22, 2019
Autologous adipose tissue grafting for the management of the painful scarKendrick To, Conor Crowley, Soo-Keat Lim, et al.
Cytotherapy|November 19, 2018
Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow-derived multipotent mesenchymal stromal cell expansion culturesMarta Grau-Vorster, Luciano Rodríguez, Sílvia Torrents-Zapata, et al.
Cytotherapy|February 17, 2019
Chimeric antigen receptor-T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goodsRichard P Harrison, Ezequiel Zylberberg, Simon Ellison, et al.
Cytotherapy|February 17, 2021
IL-37 overexpression enhances the therapeutic effect of endometrial regenerative cells in concanavalin A-induced hepatitisGuangming Li, Dejun Kong, Yafei Qin, et al.
Cytotherapy|February 17, 2021
Estimation of manufacturing development costs of cell-based therapies: a feasibility studyRenske M T Ten Ham, Julianne C Nievaart, Jarno Hoekman, et al.
Cytotherapy|January 23, 2021
Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United StatesCarolina Iglesias-Lopez, Mercè Obach, Antonio Vallano, et al.
Cytotherapy|February 21, 2021
Impact of contracted manufacturing organization protocols on operations in an aca demically based Current Good Manufacturing Practice facilityVeronica Sutherland, Mary Jo Buffo, Theresa L Whiteside
Pageof 280

Showing results (761-770 of 2,791) with videos related to

Sort By:
Pageof 280
Cytotherapy|January 30, 2017
CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: A pilot studySarita Rani Jaiswal, Shamsur Zaman, Murugaiyan Nedunchezhian, et al.
Cytotherapy|July 20, 2019
T-cell therapies for T-cell lymphomaKeri Toner, Catherine M Bollard, Hema Dave
Cytotherapy|September 22, 2019
Umbilical cord-derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical dataMartina Colicchia, Daniel A Jones, Anne-Marie Beirne, et al.
Cytotherapy|September 22, 2019
Autologous adipose tissue grafting for the management of the painful scarKendrick To, Conor Crowley, Soo-Keat Lim, et al.
Cytotherapy|November 19, 2018
Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow-derived multipotent mesenchymal stromal cell expansion culturesMarta Grau-Vorster, Luciano Rodríguez, Sílvia Torrents-Zapata, et al.
Cytotherapy|February 17, 2019
Chimeric antigen receptor-T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goodsRichard P Harrison, Ezequiel Zylberberg, Simon Ellison, et al.
Cytotherapy|February 17, 2021
IL-37 overexpression enhances the therapeutic effect of endometrial regenerative cells in concanavalin A-induced hepatitisGuangming Li, Dejun Kong, Yafei Qin, et al.
Cytotherapy|February 17, 2021
Estimation of manufacturing development costs of cell-based therapies: a feasibility studyRenske M T Ten Ham, Julianne C Nievaart, Jarno Hoekman, et al.
Cytotherapy|January 23, 2021
Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United StatesCarolina Iglesias-Lopez, Mercè Obach, Antonio Vallano, et al.
Cytotherapy|February 21, 2021
Impact of contracted manufacturing organization protocols on operations in an aca demically based Current Good Manufacturing Practice facilityVeronica Sutherland, Mary Jo Buffo, Theresa L Whiteside
Pageof 280